293 related articles for article (PubMed ID: 3978845)
21. Clinical and cytogenetic survey of institutionalized mentally retarded patients with emphasis on the fragile-X syndrome.
Butler MG; Singh DN
J Intellect Disabil Res; 1993 Apr; 37 ( Pt 2)(Pt 2):131-42. PubMed ID: 8481611
[TBL] [Abstract][Full Text] [Related]
22. Macroorchidism and fragile X in mentally retarded males. Clinical, cytogenetic, and some hormonal investigations in mentally retarded males, including two with the fragile site at Xq28, fra(X)(q28).
Nielsen KB; Tommerup N; Dyggve HV; Schou C
Hum Genet; 1982; 61(2):113-7. PubMed ID: 6215327
[TBL] [Abstract][Full Text] [Related]
23. Fragile X chromosome in institutionalized male adults with mental retardation.
Aoi T; Takashima H; Takada T; Okada T
Keio J Med; 1989 Mar; 38(1):36-9. PubMed ID: 2785613
[TBL] [Abstract][Full Text] [Related]
24. A comparison of language characteristics of mentally retarded adults with fragile X syndrome and those with nonspecific mental retardation and autism.
Paul R; Dykens E; Leckman JF; Watson M; Breg WR; Cohen DJ
J Autism Dev Disord; 1987 Dec; 17(4):457-68. PubMed ID: 3479423
[TBL] [Abstract][Full Text] [Related]
25. Frequency of the fragile X syndrome in institutionalized mentally retarded females in Japan.
Arinami T; Kondo I; Nakajima S; Hamaguchi H
Hum Genet; 1987 Aug; 76(4):344-7. PubMed ID: 3610153
[TBL] [Abstract][Full Text] [Related]
26. The inactivation of the fragile X chromosome in female carriers of the Martin Bell syndrome as studied by two different methods.
Tuckerman E; Webb T
Clin Genet; 1989 Jul; 36(1):25-30. PubMed ID: 2766560
[TBL] [Abstract][Full Text] [Related]
27. The fragile X syndrome in a large family. II. Psychological investigations.
Veenema H; Veenema T; Geraedts JP
J Med Genet; 1987 Jan; 24(1):32-8. PubMed ID: 3806640
[TBL] [Abstract][Full Text] [Related]
28. The Martin-Bell syndrome in South Africa.
Venter PA; Op't Hof J; Coetzee DJ
Am J Med Genet; 1986; 23(1-2):597-610. PubMed ID: 3953670
[TBL] [Abstract][Full Text] [Related]
29. Klinefelter syndrome and two fragile X chromosomes.
Fryns JP; Kleczkowska A; Wolfs I; van den Berghe H
Clin Genet; 1984 Nov; 26(5):445-7. PubMed ID: 6499257
[TBL] [Abstract][Full Text] [Related]
30. The fragile X syndrome.
Brown WT
Neurol Clin; 1989 Feb; 7(1):107-21. PubMed ID: 2646518
[TBL] [Abstract][Full Text] [Related]
31. Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group.
de Vries BB; Mohkamsing S; van den Ouweland AM; Mol E; Gelsema K; van Rijn M; Tibben A; Halley DJ; Duivenvoorden HJ; Oostra BA; Niermeijer MF
J Med Genet; 1999 Jun; 36(6):467-70. PubMed ID: 10874635
[TBL] [Abstract][Full Text] [Related]
32. The predictive value of dermatoglyphic anomalies in the diagnosis of fra(X)-positive Martin-Bell syndrome (MBS).
Langenbeck U; Varga I; Hansmann I
Am J Med Genet; 1988; 30(1-2):169-75. PubMed ID: 3177442
[TBL] [Abstract][Full Text] [Related]
33. Chromosomal aberrations in the mildly mentally retarded.
Göstason R; Wahlström J; Johannisson T; Holmqvist D
J Ment Defic Res; 1991 Jun; 35 ( Pt 3)():240-6. PubMed ID: 1833552
[TBL] [Abstract][Full Text] [Related]
34. Fragile site X chromosomes in mentally retarded boys.
Moon HR; Moon SY
J Korean Med Sci; 1993 Jun; 8(3):192-6. PubMed ID: 8240748
[TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of the fragile-X mental retardation syndrome with two flanking polymorphic DNA markers.
Oberlé I; Heilig R; Moisan JP; Kloepfer C; Mattéi GM; Mattéi JF; Boué J; Froster-Iskenius U; Jacobs PA; Lathrop GM
Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1016-20. PubMed ID: 3006023
[TBL] [Abstract][Full Text] [Related]
36. A systematic cytogenetic study of a population of 1170 mentally retarded and/or behaviourly disturbed patients including fragile X-screening. The Hondsberg experience.
Schreppers-Tijdink GA; Curfs LM; Wiegers A; Kleczkowska A; Fryns JP
J Genet Hum; 1988 Dec; 36(5):425-46. PubMed ID: 2975324
[TBL] [Abstract][Full Text] [Related]
37. Genetic control over fragile X chromosome expression.
Hecht F; Fryns JP; Vlietinck RF; Van den Berghe H
Clin Genet; 1986 Mar; 29(3):191-5. PubMed ID: 3698329
[TBL] [Abstract][Full Text] [Related]
38. The marker (X) syndrome: a cytogenetic and genetic analysis.
Sherman SL; Morton NE; Jacobs PA; Turner G
Ann Hum Genet; 1984 Jan; 48(1):21-37. PubMed ID: 6712153
[TBL] [Abstract][Full Text] [Related]
39. Effect of X inactivation on fragile X frequency and mental retardation.
Rosenberg C; Vianna-Morgante AM; Otto PA; Navajas L
Am J Med Genet; 1991; 38(2-3):421-4. PubMed ID: 2018084
[TBL] [Abstract][Full Text] [Related]
40. The fragile X syndrome in a large family. I. Cytogenetic and clinical investigations.
Veenema H; Geraedts JP; Beverstock GC; Pearson PL
J Med Genet; 1987 Jan; 24(1):23-31. PubMed ID: 3492604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
